IRIS
ROVIELLO, GIANDOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.013
EU - Europa 2.574
AS - Asia 1.189
SA - Sud America 179
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 62
OC - Oceania 6
Totale 8.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.949
GB - Regno Unito 615
RU - Federazione Russa 540
CN - Cina 449
IT - Italia 348
IE - Irlanda 326
SG - Singapore 297
UA - Ucraina 203
VN - Vietnam 160
SE - Svezia 158
BR - Brasile 147
HK - Hong Kong 116
FR - Francia 102
DE - Germania 93
FI - Finlandia 59
ES - Italia 36
ZA - Sudafrica 34
IN - India 33
KR - Corea 33
CA - Canada 29
BE - Belgio 18
LU - Lussemburgo 18
MX - Messico 18
BD - Bangladesh 14
AR - Argentina 13
IQ - Iraq 12
NG - Nigeria 11
IR - Iran 10
JO - Giordania 7
JP - Giappone 7
PH - Filippine 7
TR - Turchia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
AT - Austria 5
AU - Australia 5
CI - Costa d'Avorio 5
PK - Pakistan 5
PL - Polonia 5
CR - Costa Rica 4
EE - Estonia 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
NL - Olanda 4
NO - Norvegia 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
HN - Honduras 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GE - Georgia 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
MM - Myanmar 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SV - El Salvador 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 8.026
Salva come PNG Salva come JPEG
Città #
Southend 544
Fairfield 521
Dallas 380
Dublin 323
Ashburn 310
Woodbridge 245
Ann Arbor 208
Wilmington 180
Seattle 177
Jacksonville 176
Cambridge 175
San Jose 175
Houston 174
Singapore 165
Moscow 164
Chandler 151
Santa Clara 136
Milan 115
Hong Kong 112
Beijing 95
Princeton 65
New York 64
Siena 58
Nanjing 56
Los Angeles 55
Ho Chi Minh City 48
Council Bluffs 47
Seoul 33
Hanoi 32
Johannesburg 31
Columbus 30
Munich 30
Hefei 29
San Mateo 29
Málaga 28
Shenyang 28
Lauterbourg 27
Boardman 25
Shanghai 23
The Dalles 23
Dong Ket 20
Hebei 18
Brussels 17
Helsinki 17
Nanchang 17
Rome 17
San Diego 17
London 16
São Paulo 16
Figino 14
Jiaxing 14
Roodt-sur-Syre 14
Orem 13
Phoenix 13
San Francisco 13
Venezia 13
Abuja 11
Buffalo 11
Changsha 10
Zhengzhou 10
Da Nang 9
Dearborn 9
Chennai 8
Denver 8
Ningbo 8
Norwalk 8
Stockholm 8
Tianjin 8
Toronto 8
Kunming 7
Lappeenranta 7
Manchester 7
Mexico City 7
Montreal 7
North Bergen 7
Zanjan 7
Amman 6
Atlanta 6
Chicago 6
Guangzhou 6
Jinan 6
Tokyo 6
Abidjan 5
Baghdad 5
Boston 5
Brno 5
Düsseldorf 5
Miano 5
Philadelphia 5
Pisa 5
Poplar 5
Taizhou 5
Turku 5
Viareggio 5
Washington 5
Andover 4
Brasília 4
Delhi 4
Dhaka 4
Florence 4
Totale 5.822
Salva come PNG Salva come JPEG
Nome #
C-Met targeting in advanced gastric cancer: An open challenge 348
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 324
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 315
Familial aggregation of gastric cancer with microsatellite instability** 293
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 286
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 286
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 285
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 282
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 281
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 276
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 273
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 273
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 269
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 267
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 262
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 237
Apatinib in metastatic gastric cancer: can paclitaxel make the difference? 236
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 233
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 229
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status 222
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 214
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients 209
Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification 192
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer 184
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 178
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 149
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 140
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 132
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 130
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 129
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 129
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 126
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 125
Surgical management of advanced gastric cancer: An evolving issue 116
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 113
null 98
null 96
null 88
Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer 87
null 39
Totale 8.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 0 0 0 22 27 25 16 18 29 63 68 119
2022/2023572 32 35 82 71 59 114 25 41 61 31 11 10
2023/2024489 16 10 31 17 10 126 191 5 1 39 22 21
2024/2025788 19 49 109 48 114 45 8 34 50 36 110 166
2025/20262.262 168 260 307 260 433 86 231 43 57 102 144 171
2026/2027368 86 53 131 98 0 0 0 0 0 0 0 0
Totale 8.151